Related Experiment Videos
[Primary prevention of varicose bleeding: current status]
1Medizinische Universitätsklinik Freiburg.
Schweizerische Rundschau Fur Medizin Praxis = Revue Suisse De Medecine Praxis
|June 9, 1992
Summary
Surgical shunts are not recommended for preventing first-time bleeding due to higher mortality. Beta-blockers show promise for high-risk patients, unlike sclerotherapy, which has limited benefits and complications.
Area of Science:
- Hepatology
- Gastroenterology
- Clinical Medicine
Context:
- Prevention of first bleeding in patients with portal hypertension.
- Evaluation of prophylactic treatments for esophageal varices.
Purpose:
- To assess the efficacy and safety of surgical shunts, sclerotherapy, and beta-blockers for preventing the first esophageal variceal bleeding.
- To provide evidence-based recommendations for clinical practice.
Summary:
- Surgical shunts should be abandoned for primary prophylaxis of esophageal variceal bleeding due to increased mortality, despite reducing bleeding frequency.
- Sclerotherapy is not recommended for preventing first bleeding; meta-analyses show minimal benefits on bleeding risk and mortality, outweighed by complications.
- Prophylactic beta-blockers demonstrate comparable efficacy to sclerotherapy with significantly lower risks and side effects, warranting further trials to identify optimal patient subgroups.
Impact:
- Findings suggest a shift away from surgical shunts towards medical management with beta-blockers for primary prophylaxis in portal hypertension.
- Highlights the need for personalized treatment strategies based on individual patient risk factors and potential benefits of beta-blocker prophylaxis.